2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Date

Saturday, May 30, 2020

4:27pm-4:39pm: A Comparison of Temporal Gene Expression Patterns in Kidney, Heart, Liver, and Lung Transplant Biopsies

P. Halloran¹, J. Reeve¹, .. the INTERLUNG Study Group², .. the INTERHEART Study Group², .. the INTERLIVER Study Group², &. the INTERCOMEX Study Group²

Biomarkers, Immune Assessment and Clinical Outcomes III • Virtual

4:27pm-4:39pm: A Nonhuman Primate Model of Intestinal Transplantation – Technical Aspects and Early Outcomes

R. Schmitz¹, J. Yoon¹, M. Song¹, E. Jelly², A. P. Wax², S. J. Knechtle¹, D. L. Sudan¹, J. Kwun¹

Intestinal Transplantation • Virtual

4:27pm-4:39pm: A Single-Center Analysis of Using Allele-Level 11 HLA Loci Information on cPRA and Organ-Allocation Points in Kidney Transplant Candidates

C. Maguire¹, P. Muluhngwi¹, E. Kransdorf², L. Gragert³, A. R. Tambur¹

Kidney Deceased Donor Allocation I • Virtual

4:27pm-4:39pm: A Single-Center Characterization of the Living Liver Donor Evaluation Process

L. R. Herbst, A. D. Love, M. Krach, Y. Yu, L. Kurman, A. Gurakar, M. Hammami, A. M. Cameron, J. Garonzik Wang

Liver: Living Donors and Partial Grafts II • Virtual

4:27pm-4:39pm: Adult Living Donor Liver Transplantation Results in Superior Patient and Graft Survival When Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis

A. Barbetta¹, M. Aljehani², M. KIM¹, C. Tien³, A. Ahearn¹, H. Schilperoort², L. Sher¹, J. Emamaullee¹

Liver: Living Donors and Partial Grafts I • Virtual

4:27pm-4:39pm: An Evaluation of Deceased Donor Eligibility and US Organ Donation Rates

L. DeRoos¹, Y. Zhou², W. Marrero¹, M. Lavieri¹, D. Hutton³, N. Parikh⁴

All Organs: Public Policy & Allocation • Virtual

4:27pm-4:39pm: Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist and Deceased-Donor Kidney Transplant Outcomes among Older Recipients

J. Ahn¹, S. Bae¹, K. Lentine², M. Schnitzler², G. Hess³, D. Segev¹, M. McAdams-DeMarco¹

Kidney Immunosuppression: Induction Therapy • Virtual

4:27pm-4:39pm: Antibiotic Stewardship and Inpatient C. Difficile Testing in Solid Organ Transplant Recipients, the Value of Multi-Level Checks and Balances

M. Kueht, R. Britt, R. Ferren, M. Mujtaba, R. Ramirez, R. Kulkarni, A. Lea, J. Fair, D. Reynoso

Antimicrobial & Diagnostic Stewardship in Transplantation • Virtual

4:27pm-4:39pm: Assessing Immunosuppression with Immunological Testing and Surveillance Biopsies Late after Liver and Intestine Transplantation (LT, IT)

L. Remaley, R. Falik, K. Soltys, G. Bond, J. Winnier, P. Kachmar, C. Ashokkumar, A. Ganoza, A. Kepler, A. Khanna, J. Squires, P. McKiernan, J. Rudolph, F. Alissa, G. Mazariegos, R. Sindhi

Biomarkers, Immune Assessment and Clinical Outcomes IV • Virtual

4:27pm-4:39pm: ATHENA – Patient and Allograft Outcome Differences after Kidney Transplantation – Germany vs. France

F. Thaiss¹, C. Sommerer¹, B. Suwelack¹, D. Dragun¹, I. A. Hauser¹, O. Witzke¹, C. Hugo¹, P. Schenker¹, N. Kamar², P. Merville², I. Kroeger³, M. Junge³, B. Nashan¹

Immunosuppressive Drug Minimization • Virtual